Title: An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice
Authors: Rohm, M
Schafer, M
Laurent, V
Ustunel, BE
Niopek, K
Algire, C
Hautzinger, O
Sijmonsma, TP
Zota, A
Medrikova, D
Pellegata, NS
Ryden, M
Kulyte, A
Dahlman, I
Arner, P
Petrovic, N
Cannon, B
Amri, EZ
Kemp, BE
Steinberg, GR
Janovska, P
Kopecky, J
Wolfrum, C
Bluher, M
Diaz, MB
Herzig, S
Issue Year: 2016
Publisher NATURE PUBLISHING GROUP
Series Nat. Med.:
Abstract Cachexia represents a fatal energy-wasting syndrome in a large number of patients with cancer that mostly results in a pathological loss of skeletal muscle and adipose tissue. Here we show that tumor cell exposure and tumor growth in mice triggered a futile energy-wasting cycle in cultured white adipocytes and white adipose tissue (WAT), respectively. Although uncoupling protein 1 (Ucp1)-dependent thermogenesis was dispensable for tumor-induced body wasting, WAT from cachectic mice and tumor-cell-supernatant-treated adipocytes were consistently characterized by the simultaneous induction of both lipolytic and lipogenic pathways. Paradoxically, this was accompanied by an inactivated AMP-activated protein kinase (Ampk), which is normally activated in peripheral tissues during states of low cellular energy. Ampk inactivation correlated with its degradation and with upregulation of the Ampk-interacting protein Cidea. Therefore, we developed an Ampk-stabilizing peptide, ACIP, which was able to ameliorate WAT wasting in vitro and in vivo by shielding the Cidea-targeted interaction surface on Ampk. Thus, our data establish the Ucp1-independent remodeling of adipocyte lipid homeostasis as a key event in tumor-induced WAT wasting, and we propose the ACIP-dependent preservation of Ampk integrity in the WAT as a concept in future therapies for cachexia.
URI: https://publications.svi.edu.au/publications/6511
Other Identifiers 10.1038/nm.4171
Publication type Article